Population-based studies that assess long-term patterns of incidence, major aspects of treatment and survival are virtually lacking for Hodgkin lymphoma (HL) at a younger age. This study assessed the progress made for young patients with HL (<25 years at diagnosis) in the Netherlands during 1990–2015. Patient and tumour characteristics were extracted from the population-based Netherlands Cancer Registry. Time trends in incidence and mortality rates were evaluated with average annual percentage change (AAPC) analyses. Stage at diagnosis, initial treatments and site of treatment were studied in relation to observed overall survival (OS). A total of 2619 patients with HL were diagnosed between 1990 and 2015. Incidence rates increased for 18–24...
BACKGROUND: The aim of our work was to compare the treatment modalities and the survival rates in ad...
textabstractThe survival of patients diagnosed with Hodgkin lymphoma (HL) has improved from 70% to 9...
Trends in Hodgkin lymphoma (HL) survival among patients treated outside of clinical trials provide r...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
BACKGROUND: With epidemiologic analyses of population-based trends in incidence and outcomes, we asc...
Population-based studies of classical Hodgkin lymphoma (cHL) in contemporary clinical practice are s...
Background: Hodgkin lymphoma (HL) treatment protocols for children, adolescents and young adults tra...
Background: This is the first national study on trends in cancer survival and mortality for children...
Population-based studies of classical Hodgkin lymphoma (cHL) in contemporary clinical practice are s...
In this nationwide, population-based study, we assessed trends in primary treatment and survival amo...
Population-based studies of classical Hodgkin lymphoma (cHL) in contemporary clinical practice are s...
Progress against childhood and young adolescent cancer in the Netherlands The incidence of childhoo...
BackgroundHodgkin lymphoma (HL) is a treatable tumor affecting children, adolescents and young adult...
BACKGROUND: The aim of our work was to compare the treatment modalities and the survival rates in ad...
textabstractThe survival of patients diagnosed with Hodgkin lymphoma (HL) has improved from 70% to 9...
Trends in Hodgkin lymphoma (HL) survival among patients treated outside of clinical trials provide r...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
BACKGROUND: With epidemiologic analyses of population-based trends in incidence and outcomes, we asc...
Population-based studies of classical Hodgkin lymphoma (cHL) in contemporary clinical practice are s...
Background: Hodgkin lymphoma (HL) treatment protocols for children, adolescents and young adults tra...
Background: This is the first national study on trends in cancer survival and mortality for children...
Population-based studies of classical Hodgkin lymphoma (cHL) in contemporary clinical practice are s...
In this nationwide, population-based study, we assessed trends in primary treatment and survival amo...
Population-based studies of classical Hodgkin lymphoma (cHL) in contemporary clinical practice are s...
Progress against childhood and young adolescent cancer in the Netherlands The incidence of childhoo...
BackgroundHodgkin lymphoma (HL) is a treatable tumor affecting children, adolescents and young adult...
BACKGROUND: The aim of our work was to compare the treatment modalities and the survival rates in ad...
textabstractThe survival of patients diagnosed with Hodgkin lymphoma (HL) has improved from 70% to 9...
Trends in Hodgkin lymphoma (HL) survival among patients treated outside of clinical trials provide r...